Pain News and Research

Latest Pain News and Research

FDA meeting streamlines pathway to initial U.S. approval of Provectus's PV-10 oncology drug

Provectus Biopharmaceuticals, Inc. (PVCT), a development-stage oncology and dermatology biopharmaceutical company, today announced that it has received the official minutes from the Type C meeting held with the FDA's Division of Oncology Products 2 on December 16, 2013.

27 Jan 2014

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

Teva Pharmaceutical Industries Ltd. and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that both companies remain committed to the NERVENTRA® (laquinimod) clinical development program for multiple sclerosis (MS) following the announcement of a negative opinion for the treatment of relapsing-remitting multiple sclerosis (RRMS) by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

27 Jan 2014

Organ and tissue donation saves lives

OneLegacy, the non-profit, federally designated organ, eye and tissue recovery agency serving the seven-country greater Los Angeles area, today issued the following statement: "Kim Pham, the 23-year-old woman who died from her injuries after being assaulted outside a Santa Ana nightclub on Jan. 18, saved five lives through the donation of her heart, kidneys, lungs, pancreas and liver to patients on the national organ transplant waiting list.

27 Jan 2014

New pain management system for patients with painful diabetic neuropathy

From the moment people learn to walk, many are taught that exercise is the key to living a healthy life. Indeed, the long-term benefits of exercise are indisputable.

25 Jan 2014

Antibe Therapeutics increases non-brokered private placement to a total of 2.27 million units

Antibe Therapeutics Inc. ("Antibe" or the "Corporation") (TSXV:ATE) announces an increase to the size of its non-brokered private placement to a total of approximately 2.27 million units (the "Units") at a price of $0.55 per Unit, from the previously announced total of approximately 1.8 million Units, each Unit comprised of one Common Share of the Corporation and one-half of one Common Share purchase warrant ("Warrant") with each whole Warrant entitling the holder to purchase an additional Common Share ("Warrant Share") at a price of $0.80 per Warrant Share for a term of thirty-six (36) months following the date of issuance, for gross proceeds of up to $1.25 million (the "Offering").

25 Jan 2014

Research roundup: Patient safety measure results 'disappointing'

Patient safety poses serious challenges to the health care system in the United States. Since 2001, nationwide efforts have focused on reducing in-hospital adverse events.

25 Jan 2014

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

The Gagnon Cardiovascular Institute at Morristown Medical Center today became the first hospital in the tri-state area to adopt a new minimally invasive medical device to treat patients with severe aortic stenosis who are too ill or frail to have their aortic valves replaced trough traditional open-heart surgery.

25 Jan 2014

BIDMC aims to improve family engagement and reduce overall risk of harm in ICU

Beth Israel Deaconess Medical Center is embarking on a new phase of its mission to eliminate preventable harm, using information technology and system science together with patient and family engagement to head off harm before it happens.

25 Jan 2014

Patient enrollment completed for Venaxis' pivotal clinical study of APPY1 Test

Venaxis, Inc., an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States.

24 Jan 2014

Researchers locate two molecules involved in perpetuating chronic pain

Setting the stage for possible advances in pain treatment, researchers at The Johns Hopkins University and the University of Maryland report they have pinpointed two molecules involved in perpetuating chronic pain in mice. The molecules, they say, also appear to have a role in the phenomenon that causes uninjured areas of the body to be more sensitive to pain when an area nearby has been hurt.

24 Jan 2014

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

A collaboration of surgeons at Henry Ford Hospital and Medanta Hospital in India successfully transplanted kidneys into 50 recipients using an innovative robot-assisted procedure in which the organ is cooled with sterile ice during the operation.

24 Jan 2014

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

Beth Israel Deaconess Medical Center (BIDMC) yesterday became the first institution in the United States to use a new minimally invasive medical device since it received FDA approval last week.

From Medtronic 24 Jan 2014

Pfizer announces results from Phase 3 study of ALO-02 in patients with chronic low back pain

Pfizer Inc. (NYSE: PFE) announced today top-line results from a Phase 3 study of investigational agent ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules) in patients with moderate-to-severe chronic low back pain.

24 Jan 2014

Doctor offers tips to prevent injuries while shoveling snow

As temperatures continue to plunge and snowfall levels increase across the tri-state region, a physical therapy professor at University of the Sciences in Philadelphia reminds individuals the exertion, cold weather, and slippery surfaces snow shovelers face in these conditions are a dangerous combination.

24 Jan 2014

Continuing spinal cord stimulation improves symptoms of Parkinson's disease

Researchers at Duke Medicine have shown that continuing spinal cord stimulation appears to produce improvements in symptoms of Parkinson's disease, and may protect critical neurons from injury or deterioration.

24 Jan 2014

New easy-to-use risk calculator helps predict heart failure patients' chances of survival

A UCLA team has developed an easy-to-use "risk calculator" that helps predict heart failure patients' chances of survival for up to five years and assists doctors in determining whether more or less aggressive treatment is appropriate.

23 Jan 2014

Acclarent announces availability of Relieva Spin Balloon Sinuplasty System for sinusitis treatment

Acclarent, Inc. announced today the U.S. availability of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed to access small and tight sinus anatomy in children and adults. This innovation represents a new addition to Acclarent's Balloon Sinuplasty portfolio, which physicians use to treat children who suffer from chronic maxillary sinusitis.

23 Jan 2014

FDA grants final approval for Hi-Tech Pharmacal's Bromfenac Ophthalmic Solution ANDA

Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, granted final approval for the Company's Abbreviated New Drug Application, for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day), the generic for ISTA Pharmaceuticals' Bromday ophthalmic solution, 0.09%.

23 Jan 2014

Gulf Coast Spine Care now offers new, improved treatment for degenerative disc disease

Degenerative disc disease affects many individuals, and it can cause a significant amount of pain to those affected. Its most common cause is related to aging and deterioration of the bones in the spine, and pain from the condition results when two or more vertebrae move and place pressure on the spine. This is a condition that often is associated with both a herniated disc and spinal stenosis.

23 Jan 2014

Home-based hospice practices for hospitalized patients could improve end-of-life care

A study by researchers at the Birmingham Veterans Affairs Medical Center and the University of Alabama at Birmingham says using home-based hospice practices for terminally ill, hospitalized patients could reduce suffering and improve end-of-life care.

23 Jan 2014

Pain News and Research

Latest Pain News and Research

FDA meeting streamlines pathway to initial U.S. approval of Provectus's PV-10 oncology drug

Active Biotech, Teva remain committed to NERVENTRA clinical development program for multiple sclerosis

Organ and tissue donation saves lives

New pain management system for patients with painful diabetic neuropathy

Antibe Therapeutics increases non-brokered private placement to a total of 2.27 million units

Research roundup: Patient safety measure results 'disappointing'

Gagnon Cardiovascular Institute adopt new medical device to treat patients with severe aortic stenosis

BIDMC aims to improve family engagement and reduce overall risk of harm in ICU

Patient enrollment completed for Venaxis' pivotal clinical study of APPY1 Test

Researchers locate two molecules involved in perpetuating chronic pain

Minimally invasive robotic surgery: A safe alternative to traditional open surgery

BIDMC receives FDA approval to use new medical device in patients with severely damaged aortic heart valves

Pfizer announces results from Phase 3 study of ALO-02 in patients with chronic low back pain

Doctor offers tips to prevent injuries while shoveling snow

Continuing spinal cord stimulation improves symptoms of Parkinson's disease

New easy-to-use risk calculator helps predict heart failure patients' chances of survival

Acclarent announces availability of Relieva Spin Balloon Sinuplasty System for sinusitis treatment

FDA grants final approval for Hi-Tech Pharmacal's Bromfenac Ophthalmic Solution ANDA

Gulf Coast Spine Care now offers new, improved treatment for degenerative disc disease

Home-based hospice practices for hospitalized patients could improve end-of-life care

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Pain News and Research

Latest Pain News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in